DNA Analysis of Blood and Tissue From Patients With Lung Cancer
ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorMassachusetts General Hospital
About this trial
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future.
PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Newly diagnosed primary lung cancer
Patient at Massachusetts General Hospital (MGH) or Boston Medical Center Cancer Center
Not specified
Not specified
Disqualifiers
None
Trial population
Patients with lung cancer
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Metabolic polymorphisms
to compare differences among lung cancer patients
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Massachusetts General Hospital
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov